BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31698767)

  • 1. Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro.
    Brezgin S; Kostyusheva A; Bayurova E; Gordeychuk I; Isaguliants M; Goptar I; Nikiforova A; Smirnov V; Volchkova E; Glebe D; Kostyushev D; Chulanov V
    Microorganisms; 2019 Nov; 7(11):. PubMed ID: 31698767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p.
    Faure-Dupuy S; Riedl T; Rolland M; Hizir Z; Reisinger F; Neuhaus K; Schuehle S; Remouchamps C; Gillet N; Schönung M; Stadler M; Wettengel J; Barnault R; Parent R; Schuster LC; Farhat R; Prokosch S; Leuchtenberger C; Öllinger R; Engleitner T; Rippe K; Rad R; Unger K; Tscharahganeh D; Lipka DB; Protzer U; Durantel D; Lucifora J; Dejardin E; Heikenwälder M
    JHEP Rep; 2021 Dec; 3(6):100354. PubMed ID: 34704004
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Tu T; Zehnder B; Qu B; Urban S
    JHEP Rep; 2021 Feb; 3(1):100195. PubMed ID: 33385130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9.
    Kostyushev D; Kostyusheva A; Brezgin S; Ponomareva N; Zakirova NF; Egorshina A; Yanvarev DV; Bayurova E; Sudina A; Goptar I; Nikiforova A; Dunaeva E; Lisitsa T; Abramov I; Frolova A; Lukashev A; Gordeychuk I; Zamyatnin AA; Ivanov A; Chulanov V
    Mol Ther Nucleic Acids; 2023 Mar; 31():482-493. PubMed ID: 36865089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
    Xia Y; Stadler D; Lucifora J; Reisinger F; Webb D; Hösel M; Michler T; Wisskirchen K; Cheng X; Zhang K; Chou WM; Wettengel JM; Malo A; Bohne F; Hoffmann D; Eyer F; Thimme R; Falk CS; Thasler WE; Heikenwalder M; Protzer U
    Gastroenterology; 2016 Jan; 150(1):194-205. PubMed ID: 26416327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage.
    Wang Y; Li Y; Zai W; Hu K; Zhu Y; Deng Q; Wu M; Li Y; Chen J; Yuan Z
    Hepatology; 2022 May; 75(5):1275-1288. PubMed ID: 34779008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
    Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
    J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
    Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
    J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.
    Dong C; Qu L; Wang H; Wei L; Dong Y; Xiong S
    Antiviral Res; 2015 Jun; 118():110-7. PubMed ID: 25843425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
    Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
    J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Interacting with Promyelocytic Leukemia Protein.
    Li Y; He M; Gong R; Wang Z; Lu L; Peng S; Duan Z; Feng Y; Liu Y; Gao B
    J Virol; 2022 Jul; 96(13):e0054622. PubMed ID: 35695580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
    Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
    Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
    Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
    Peng B; Jing Z; Zhou Z; Sun Y; Guo G; Tan Z; Diao Y; Yao Q; Ping Y; Li X; Ren T; Li B; Li W
    J Virol; 2023 Jan; 97(1):e0171722. PubMed ID: 36475867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.
    Kitamura K; Que L; Shimadu M; Koura M; Ishihara Y; Wakae K; Nakamura T; Watashi K; Wakita T; Muramatsu M
    PLoS Pathog; 2018 Jun; 14(6):e1007124. PubMed ID: 29928064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus covalently closed circular DNA homeostasis is independent of the lymphotoxin pathway during chronic HBV infection.
    Meier MA; Suslov A; Ketterer S; Heim MH; Wieland SF
    J Viral Hepat; 2017 Aug; 24(8):662-671. PubMed ID: 28182305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
    Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
    J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA.
    Xu Z; Zhao L; Zhong Y; Zhu C; Zhao K; Teng Y; Cheng X; Chen Q; Xia Y
    Cell Mol Gastroenterol Hepatol; 2022; 13(4):1001-1017. PubMed ID: 34896285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA.
    Tang L; Sheraz M; McGrane M; Chang J; Guo JT
    PLoS Pathog; 2019 Apr; 15(4):e1007742. PubMed ID: 31026293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.